Our Pricing

Compare Omeprazole Strengths for Acid Reflux Treatment

When comparing omeprazole strengths uk comparison options, understanding the differences between 10mg and 20mg formulations—and how they compare to alternative PPIs—helps you choose the most effective treatment for your acid reflux symptoms. At Cured Pharmacy, our UK-registered clinical team can assess which proton pump inhibitor strength is right for your specific needs, with prices starting from £9.99.

Understanding Omeprazole Strengths: 10mg vs 20mg

Omeprazole, the UK's most prescribed proton pump inhibitor, is available in two primary strengths: 10mg and 20mg capsules [1]. The lower 10mg dose is typically recommended for mild, occasional heartburn or maintenance therapy after initial symptom control, whilst 20mg serves as the standard treatment dose for moderate to severe gastro-oesophageal reflux disease (GORD) [1].

Clinical trials demonstrate that omeprazole 20mg achieves healing rates of approximately 80-85% in erosive oesophagitis after four weeks of treatment, compared to 60-65% with the 10mg dose [2]. The higher strength works by more completely blocking gastric acid secretion—reducing stomach acid production by up to 90% within 24 hours of the first dose [1].

For most patients experiencing frequent heartburn (two or more episodes weekly), UK prescribers typically initiate treatment with 20mg once daily, taken 30 minutes before breakfast. After symptom control is achieved—usually within 2-4 weeks—some patients may step down to 10mg for long-term maintenance, though this requires clinical assessment to ensure adequate acid suppression [2].

How Omeprazole Compares to Alternative PPI Strengths

Whilst omeprazole remains the gold-standard PPI in UK clinical practice, several alternative proton pump inhibitors offer different strength profiles and pharmacological advantages. Esomeprazole 20mg—the S-isomer of omeprazole—provides more consistent acid suppression and achieves therapeutic levels approximately 30% faster than standard omeprazole 20mg [3].

Lansoprazole is available in 15mg and 30mg strengths, with the 30mg dose demonstrating comparable efficacy to omeprazole 20mg in head-to-head trials [4]. Some patients who experience incomplete symptom relief on omeprazole 20mg may respond better to lansoprazole 30mg due to individual variations in hepatic metabolism—particularly in rapid CYP2C19 metabolisers who break down omeprazole more quickly [3].

Pantoprazole, offered in 20mg and 40mg gastro-resistant formulations, exhibits a slightly different pharmacokinetic profile with less potential for drug interactions—making it particularly suitable for patients on multiple medications [4]. The 40mg strength provides acid suppression equivalent to omeprazole 20mg but with more predictable absorption regardless of food intake.

Choosing Between PPI Strengths

Your UK prescriber will determine the appropriate PPI strength based on symptom severity, treatment history, and individual response. Factors influencing this decision include the frequency and intensity of heartburn episodes, presence of oesophageal inflammation on endoscopy, concurrent medications that may interact with specific PPIs, and previous treatment outcomes [2].

Patients with erosive oesophagitis typically require higher-strength PPIs (omeprazole 20mg, lansoprazole 30mg, or pantoprazole 40mg) for initial healing, whilst those with non-erosive reflux disease may achieve adequate control with lower doses. All prescription-strength PPIs require clinical assessment by a UK prescriber to ensure appropriate selection and monitoring [3].

Brand vs Generic Omeprazole Strength Equivalence

Generic omeprazole capsules contain the same active pharmaceutical ingredient and strength as branded formulations like Losec, with identical bioavailability and clinical efficacy [1]. UK medicines regulations require generic manufacturers to demonstrate therapeutic equivalence through rigorous bioequivalence studies—ensuring that generic omeprazole 20mg delivers the same acid-suppressing effect as Losec 20mg [5].

The primary differences lie in formulation excipients, capsule appearance, and price point. At Cured Pharmacy, generic omeprazole capsules start from £9.99, whilst branded Losec begins at £9.99—both requiring the same clinical assessment and delivering equivalent therapeutic outcomes. Some patients prefer branded options for consistency of appearance or specific formulation preferences, though clinical effectiveness remains identical [5].

Pyrocalm 20mg represents an over-the-counter omeprazole option available without prescription for short-term use (maximum 14 days), priced from £9.99. However, for ongoing acid reflux management beyond two weeks, prescription-strength omeprazole through clinical assessment allows for appropriate monitoring and dose optimisation [1].

Omeprazole Strength Selection for Different Conditions

The appropriate omeprazole strength varies significantly based on your specific acid-related condition. For uncomplicated GORD with typical heartburn symptoms, omeprazole 20mg once daily for 4-8 weeks achieves symptom resolution in approximately 85% of patients [2]. Those with milder, intermittent symptoms may find omeprazole 10mg taken as needed provides adequate relief without daily dosing.

Patients with peptic ulcer disease typically require omeprazole 20mg twice daily when combined with antibiotics for Helicobacter pylori eradication, or 40mg once daily for NSAID-associated ulcers [4]. This higher total daily dose ensures sufficient acid suppression to promote ulcer healing—particularly important when mucosal damage is present.

For Zollinger-Ellison syndrome and other hypersecretory conditions, initial doses may reach 60-120mg daily, divided into multiple administrations. However, such specialist dosing requires consultant gastroenterologist supervision and is not typically initiated in primary care settings [4].

Adjusting Omeprazole Strength Over Time

Long-term PPI therapy should employ the lowest effective strength that maintains symptom control—a principle known as step-down therapy [2]. After achieving initial symptom resolution with omeprazole 20mg, many patients can reduce to 10mg daily or even on-demand dosing whilst maintaining adequate reflux control.

UK clinical guidelines recommend attempting dose reduction after 4-8 weeks of successful treatment, with careful monitoring for symptom recurrence. Approximately 30-40% of patients can successfully step down to lower strengths or intermittent dosing, reducing medication burden and potential long-term risks associated with continuous high-dose PPI use [3]. Your prescriber will guide this process through regular clinical review.

Alternative PPI Formulations Beyond Standard Strengths

Beyond conventional capsule strengths, several alternative PPI formulations offer practical advantages for specific patient populations. Zoton FasTab contains lansoprazole 30mg in an orodispersible tablet that dissolves on the tongue within seconds—ideal for patients with swallowing difficulties or those who cannot take capsules [4]. This formulation, available from £9.99, delivers equivalent acid suppression to standard lansoprazole capsules.

Nexium 40mg tablets provide esomeprazole in a higher strength than the standard 20mg dose, offering more potent acid suppression for patients with inadequate response to conventional PPI doses [3]. The 40mg strength achieves intragastric pH >4 for approximately 17 hours per day—significantly longer than omeprazole 20mg at 12-14 hours [3].

Gastro-resistant formulations like pantoprazole tablets feature enteric coatings that prevent premature drug release in the acidic stomach environment, ensuring optimal absorption in the small intestine. This technology maintains drug stability and ensures consistent bioavailability regardless of gastric pH variations [5].

Getting the Right Omeprazole Strength at Cured Pharmacy

At Cured Pharmacy, our UK-registered prescribers assess your acid reflux symptoms, medical history, and previous treatment responses to determine the most appropriate PPI strength and formulation. The free online consultation takes under three minutes and covers symptom frequency, severity, red-flag symptoms requiring urgent investigation, concurrent medications, and treatment goals [1].

Our transparent pricing model shows exact costs before consultation—generic omeprazole capsules start from £9.99, with alternative PPIs like esomeprazole from £9.99, lansoprazole from £9.99, and pantoprazole from £9.99. All prices include clinical assessment by our UK prescribers, with no hidden fees or subscription requirements.

Following prescriber approval, medications are dispensed by our GPhC-registered pharmacy (9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073) and delivered in 100% discreet packaging. Our clinical team remains available for dosing questions, side effect management, and treatment optimisation throughout your therapy—ensuring you receive the right PPI strength for sustained symptom control [2].

Starting Your Assessment

To begin your clinical assessment for omeprazole or alternative PPI strengths, complete our online consultation form with details about your reflux symptoms, previous treatments, and medical conditions. Our UK prescribers review each submission individually—there are no automated approvals—ensuring personalised strength selection based on your specific clinical presentation [5].

Most consultations receive prescriber review within 24 hours, with approved treatments dispatched for next-day delivery across the UK. If your symptoms suggest a condition requiring in-person assessment—such as alarm features indicating potential complications—our prescribers will recommend appropriate NHS or private gastroenterology referral to ensure your safety.

Scientific References

1. Stedman, C. A., & Barclay, M. L. (2000). Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963–978. https://doi.org/10.1046/j.1365-2036.2000.00788.x
2. National Institute for Health and Care Excellence. (2014). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (Clinical guideline CG184). NICE. https://www.nice.org.uk/guidance/cg184
3. Kirchheiner, J., Glatt, S., Fuhr, U., Klotz, U., Meineke, I., Seufferlein, T., & Brockmöller, J. (2009). Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH. European Journal of Clinical Pharmacology, 65(1), 19–31. https://doi.org/10.1007/s00228-008-0576-5
4. Shin, J. M., & Sachs, G. (2008). Pharmacology of proton pump inhibitors. Current Gastroenterology Reports, 10(6), 528–534. https://doi.org/10.1007/s11894-008-0098-4
5. Medicines and Healthcare products Regulatory Agency. (2021). Proton pump inhibitors in the UK: Safety review. MHRA Drug Safety Update, 14(9). https://www.gov.uk/drug-safety-update/proton-pump-inhibitors-ppis-very-low-risk-of-sub-acute-cutaneous-lupus-erythematosus

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.